Cytokeratin 20 (CK20) is frequently used to diagnose MCC as it is typically negative in other small round blue cell pathologies, including metastatic SCLC (negative in 94% of SCLC cases) [7–10]. This evidence concerns the gene KRT20 and Merkel cell skin cancer.